Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02613260 · ClinicalTrials.gov registry record · NA

Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System

A NA study of Colonic Neoplasms, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
13,470
Enrollment target
1
Study location

NCT02613260 is a NA study of Colonic Neoplasms that has completed, run by University of California, San Francisco. The registered enrollment target is 13,470 participants, above the 561-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (2301% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02613260, a NA study of Colonic Neoplasms, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
13,470 participants
Enrollment target
1
Study location

Study Summary

Uptake of colorectal cancer (CRC) screening is suboptimal in the San Francisco Health Network and access to care may be limited so novel models of health care delivery are warranted. The objective of this study is to examine whether a centralized panel management model with mailed fecal immunochemical test (FIT) will be effective at increasing the uptake of CRC screening and could be developed and sustained within the typical parameters of cost-effectiveness and budget impact analyses.

Conditions Studied

Interventions

  • BEHAVIORAL FIT Outreach

Study Locations (1)

California

  • University of California, San Francisco-San Francisco General Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 13,470 participants
Start Date 2016-01-01
Est. Completion 2019-01-01
Phase NA

What the Registry Record Tells You About NCT02613260

The ClinicalTrials.gov registry entry for NCT02613260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13,470 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 561-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (2301% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which FIT Outreach is the first listed.

NCT02613260 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02613260 about?

NCT02613260 is a clinical study titled "Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System". Uptake of colorectal cancer (CRC) screening is suboptimal in the San Francisco Health Network and access to care may be limited so novel models of health care delivery are warranted. The objective of this study is to examine whether a centralized panel management model with mailed fecal immunochemic...

What is the current status of trial NCT02613260?

This trial is currently completed. It is a NA study. The enrollment target is 13,470 participants. The study started on 2016-01-01. Estimated completion is 2019-01-01.

What conditions does trial NCT02613260 study?

This clinical trial studies the following conditions: Colonic Neoplasms.

What interventions are being tested in trial NCT02613260?

The interventions under investigation include: FIT Outreach (BEHAVIORAL).

Who is sponsoring clinical trial NCT02613260?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02613260 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonic Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.